Pliant Therapeutics, Inc.
PLRX
$1.34
$0.032.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -149.34M | -175.50M | -206.96M | -219.52M | -210.30M |
| Total Depreciation and Amortization | 1.70M | 1.79M | 1.89M | 2.06M | 2.13M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.25M | 37.58M | 40.76M | 43.24M | 43.59M |
| Change in Net Operating Assets | -15.94M | -22.08M | -5.09M | 122.00K | 9.09M |
| Cash from Operations | -128.34M | -158.21M | -169.40M | -174.10M | -155.50M |
| Capital Expenditure | -374.00K | -583.00K | -1.48M | -2.62M | -3.85M |
| Sale of Property, Plant, and Equipment | 155.00K | 156.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 134.51M | 172.08M | 176.17M | 152.53M | 144.19M |
| Cash from Investing | 134.29M | 171.65M | 174.69M | 149.91M | 140.34M |
| Total Debt Issued | -- | 1.00K | 1.00K | 1.00K | 19.91M |
| Total Debt Repaid | -32.27M | -- | -- | -- | -- |
| Issuance of Common Stock | 570.00K | 671.00K | 1.14M | 1.83M | 3.21M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -31.70M | 672.00K | 1.14M | 1.83M | 23.12M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.74M | 14.12M | 6.43M | -22.36M | 7.95M |